PharmaSource Podcast

Pharma Supply Chain Sustainability: How Sanofi, Sharp Services and My Green Lab Are Moving From Commitment to Execution

“If our suppliers fail, we’ll fail, and if they succeed, we’ll succeed.” That’s how José Francisco Vallejo Cabrera of Sanofi describes big pharma’s relationship with its

How Axplora Uses Strategic CDMO Partnerships to Take 6-9 Months Off ADC Payload Timelines

“You have to have something to work on together. You have to have something that you both are invested in. In this case, moving the molecule forward,” says Martin Meeson,

How Piramal Built Patient Centricity Into 15 Global CDMO Sites

“To us, it’s exactly the opposite of a marketing slogan. If we make a decision that has a negative impact on a patient, we’ve made a bad decision,” says Stuart Needleman.

7 Lessons on Pharma Data Quality and Digital Transformation from Sakara Digital's Amie Harpe

“If the data you give it is weak, the model becomes a liability rather than an asset. In regulated industries, that’s not just a technical failure; it’s potentially a com

Three Packaging Bottlenecks Slowing GLP-1 Scale-Up

At CDMO Live Europe 2026, Alexander Schäfer, Business Development Manager at Sharp, laid out the scale of the GLP-1 packaging challenge and identified the three collabora

Container Closure Integrity: 6 Considerations for Evaluating CDMO Capabilities

Container closure integrity (CCI) is a critical element of sterile product quality, but evaluating a CDMO’s CCI capabilities requires more than confirming that testing is

How to Select and Sustain an Early-Stage CDMO Partnership

At CDMO Live Europe 2026, Giulio Cavalli, Principal Lead External Manufacturing, J&J Innovative Medicine; Neil Stevenson, Director, CMC Logic Consultancy; Marine Joly Bat

What Changes When Pharma Outsources Outcomes, Not Just People?

“Traditional staff augmentation says, ‘Here are the people you asked for.’ An outcome-led model says, ‘Here is the service or capability you asked for, and we are account

Europe Needs to Pick a Side: Why Geopolitics Is Forcing a Rethink of Pharma Supply Network Design

Sponsored by Blue Jet Healthcare, this panel at CDMO Live Europe 2026 brought together Bernhard Boehm, Head of External Manufacturing Animal Health, Boehringer Ingelheim;

AI in Biopharma Manufacturing: Why Build-or-Buy Is the Wrong First Question

“AI is marketed as such an approachable, ubiquitous thing that everybody thinks they can vibe code it. Unfortunately, a lot of companies are starting to think that way,”

What CDMOs Get Wrong About AI for Bioprocessing, According to Sapiens Health’s Seungik Cho

“How good is your AI model? That’s the wrong question. The right question is: what does your AI model actually help your company do?” Seungik Cho, founder of Sapiens Hea

How to Identify a Root Cause Without Delay: Interlabor's Troubleshooting Framework

At CDMO Live Europe 2026, Dr. Olivier Aebischer, Deputy CEO at Interlabor Belp AG, demonstrated how a structured, dual-path analytical approach can identify manufacturing

How ExoZymes Is Running a 10-CDMO RFP for CDMO Selection

“We can adjust and be flexible around equipment configuration, but we can’t be flexible around what is a clear communicator and an honest partner.” Damien Perriman is Ch

How EU Sustainability Regulations Are Reshaping CDMO Manufacturing

“Rather than saying that there’s a gap from the industry, I think there’s a listening gap from our governments.” Neha Dave is an independent EU Government Affairs Adviso

"Stop Talking About Resilience in the Future Tense": What Pharma Actually Wants From CDMOs

Moderated by Raman Sehgal, Host of Molecule to Market, this opening panel at CDMO Live Europe 2026 brought together Melanie Wamsler, External Network Strategy Lead, Taked

Abzena on AOCs: Building US Capacity to Compete With China

“There isn’t enough capacity for antibody-oligo conjugates out there today, full stop,” says Geoff Glass, CEO of Abzena. “And it’s really because of the volume requiremen

“Mexico Is the New China”: Reshoring Institute Executive Director Rosemary Coates on the Future of Pharmaceutical Reshoring

“If you look at the employment numbers in the manufacturing sector, it’s been absolutely flat for two years. The political noise has not driven that big wave of reshoring

How Cognition Therapeutics Cut Cost of Goods by 85% Through Smarter CMC Strategy

“No one is going to care about your project as much as you do.”  Steven Weissman is Vice President and Head of CMC at Cognition Therapeutics, a small pharma company outs

How to Connect a CDMO Network Without Starting From Scratch

“Digital collaboration is a competitive advantage for everyone — for CDMOs and CMOs, it’s not a question of if you’re going to do it, it’s when. So how do you get ready f

CDMO Relationship Management Across the Americas: Why Culture Changes Everything

“When we go to an external partner, we need to show up as one single aligned organization. If we’re not aligned internally, the CMO ends up becoming the referee.” In ph